(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Kosmos Energy, Innodata, and SmileDirectClub.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Kosmos Energy (KOS) | 8.48 | 12.17% | 2023-02-27 15:45:45 |
| 2 | Innodata (INOD) | 7.22 | 11.76% | 2023-02-27 05:15:12 |
| 3 | SmileDirectClub (SDC) | 0.54 | 11% | 2023-02-27 12:04:14 |
| 4 | Seattle Genetics (SGEN) | 177.20 | 9.81% | 2023-02-27 13:00:22 |
| 5 | Union Pacific Corporation (UNP) | 210.51 | 9.23% | 2023-02-27 13:13:13 |
| 6 | AMC (AMC) | 6.67 | 7.64% | 2023-02-27 13:06:19 |
| 7 | iShares FTSE EPRA/NAREIT Europe (IFEU) | 35.08 | 7.21% | 2023-02-27 03:47:15 |
| 8 | Chart Industries (GTLS) | 138.87 | 6.07% | 2023-02-26 19:46:16 |
| 9 | Marathon (MARA) | 7.07 | 5.92% | 2023-02-27 12:58:39 |
| 10 | Baidu (BIDU) | 139.94 | 5.61% | 2023-02-27 12:54:34 |
The three biggest losers today are Inogen, Infinity Pharmaceuticals, and FuboTV.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Inogen (INGN) | 15.89 | -31.39% | 2023-02-27 05:14:12 |
| 2 | Infinity Pharmaceuticals (INFI) | 0.24 | -13.32% | 2023-02-27 05:12:13 |
| 3 | FuboTV (FUBO) | 2.03 | -12.72% | 2023-02-27 15:52:41 |
| 4 | Heron Therapeutics (HRTX) | 2.28 | -11.63% | 2023-02-26 23:46:16 |
| 5 | LendingTree (TREE) | 33.46 | -10.17% | 2023-02-27 13:00:59 |
| 6 | Professional Diversity Network (IPDN) | 6.94 | -9.1% | 2023-02-27 07:09:12 |
| 7 | Aspen Group (ASPU) | 0.16 | -9.07% | 2023-02-27 11:46:31 |
| 8 | VerifyMe (VRME) | 1.77 | -6.84% | 2023-02-27 14:23:09 |
| 9 | Xenetic Biosciences (XBIO) | 0.53 | -5.75% | 2023-02-27 12:35:12 |
| 10 | Infinera Corporation (INFN) | 6.83 | -5.27% | 2023-02-27 05:13:09 |
Winners today
1. Kosmos Energy (KOS) – 12.17%
Kosmos Energy Ltd., a deep-water independent oil and gas exploration and production company, focuses along the Atlantic Margins. The company's primary assets include production offshore Ghana, Equatorial Guinea, and the U.S. Gulf of Mexico, as well as a gas development offshore Mauritania and Senegal. It also maintains a proven basin exploration program. The company was founded in 2003 and is headquartered in Dallas, Texas.
NYSE ended the session with Kosmos Energy jumping 12.17% to $8.48 on Monday, after two consecutive sessions in a row of gains. NYSE jumped 0.14% to $15,486.46, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Kosmos Energy has a trailing twelve months EPS of $-1.02.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 74.48%.
Yearly Top and Bottom Value
Kosmos Energy’s stock is valued at $8.48 at 16:32 EST, below its 52-week high of $8.49 and way higher than its 52-week low of $4.44.
Sales Growth
Kosmos Energy’s sales growth is negative 7.3% for the present quarter and negative 14.5% for the next.
Volatility
Kosmos Energy’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.20%, a negative 0.65%, and a positive 2.69%.
Kosmos Energy’s highest amplitude of average volatility was 1.08% (last week), 2.48% (last month), and 2.69% (last quarter).
Moving Average
Kosmos Energy’s worth is way higher than its 50-day moving average of $7.08 and way higher than its 200-day moving average of $6.58.
More news about Kosmos Energy.
2. Innodata (INOD) – 11.76%
Innodata Inc. operates as a global data engineering company in the United States, the United Kingdom, the Netherlands, Canada, and internationally. The company operates through three segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment offers a range of solutions and platforms for solving data challenges that companies face when they seek to obtain the benefits of artificial intelligence systems and analytics platforms, including data annotation, data transformation, data curation, and intelligent automation. This segment also provides services for clients in the information industry that relate to content operations and product development. The Synodex segment offers an intelligent data platform that transforms medical records into useable digital data with its proprietary data models or client data models. The Agility segment provides an intelligent data platform that provides marketing communications and public relations professionals to target and distribute content to journalists and social media influencers; and to monitor and analyze global news channels, such as print, web, radio, and TV, as well as and social media channels. It serves banking, insurance, financial services, technology, digital retailing, and information/media sectors through its professional staff, senior management, and direct sales personnel. The company was formerly known as Innodata Isogen, Inc. and changed its name to Innodata Inc. in June 2012. Innodata Inc. was founded in 1988 and is headquartered in Ridgefield Park, New Jersey.
NASDAQ ended the session with Innodata jumping 11.76% to $7.22 on Monday while NASDAQ jumped 0.63% to $11,466.98.
Earnings Per Share
As for profitability, Innodata has a trailing twelve months EPS of $-0.45.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -54.01%.
Moving Average
Innodata’s worth is way higher than its 50-day moving average of $4.21 and way higher than its 200-day moving average of $4.29.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 79M for the twelve trailing months.
Yearly Top and Bottom Value
Innodata’s stock is valued at $7.22 at 16:32 EST, way under its 52-week high of $9.00 and way higher than its 52-week low of $2.78.
More news about Innodata.
3. SmileDirectClub (SDC) – 11%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub rising 11% to $0.54 on Monday, after five consecutive sessions in a row of losses. NASDAQ rose 0.63% to $11,466.98, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.334.
Moving Average
SmileDirectClub’s worth is above its 50-day moving average of $0.52 and way under its 200-day moving average of $0.93.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 16% and 26.3%, respectively.
Volatility
SmileDirectClub’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.85%, a negative 0.64%, and a positive 7.04%.
SmileDirectClub’s highest amplitude of average volatility was 4.85% (last week), 5.34% (last month), and 7.04% (last quarter).
More news about SmileDirectClub.
4. Seattle Genetics (SGEN) – 9.81%
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.
NASDAQ ended the session with Seattle Genetics rising 9.81% to $177.20 on Monday while NASDAQ jumped 0.63% to $11,466.98.
Earnings Per Share
As for profitability, Seattle Genetics has a trailing twelve months EPS of $3.58.
PE Ratio
Seattle Genetics has a trailing twelve months price to earnings ratio of 49.44. Meaning, the purchaser of the share is investing $49.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.27%.
More news about Seattle Genetics.
5. Union Pacific Corporation (UNP) – 9.23%
Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates in the railroad business in the United States. The company offers transportation services for grain and grain products, fertilizers, food and refrigerated products, and coal and renewables to grain processors, animal feeders, ethanol producers, and other agricultural users; petroleum, and liquid petroleum gases; and construction products, industrial chemicals, plastics, forest products, specialized products, metals and ores, soda ash, and sand, as well as finished automobiles, automotive parts, and merchandise in intermodal containers. As of December 31, 2021, its rail network included 32,452 route miles connecting Pacific Coast and Gulf Coast ports with the Midwest and Eastern United States gateways. The company was founded in 1862 and is headquartered in Omaha, Nebraska.
NYSE ended the session with Union Pacific Corporation rising 9.23% to $210.51 on Monday while NYSE jumped 0.14% to $15,486.46.
Earnings Per Share
As for profitability, Union Pacific Corporation has a trailing twelve months EPS of $7.73.
PE Ratio
Union Pacific Corporation has a trailing twelve months price to earnings ratio of 27.24. Meaning, the purchaser of the share is investing $27.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.17%.
Volume
Today’s last reported volume for Union Pacific Corporation is 8429260 which is 190.94% above its average volume of 2897200.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 15, 2022, the estimated forward annual dividend rate is 5.2 and the estimated forward annual dividend yield is 2.51%.
Yearly Top and Bottom Value
Union Pacific Corporation’s stock is valued at $210.51 at 16:32 EST, way under its 52-week high of $278.94 and way higher than its 52-week low of $183.70.
Moving Average
Union Pacific Corporation’s value is above its 50-day moving average of $206.81 and below its 200-day moving average of $212.70.
More news about Union Pacific Corporation.
6. AMC (AMC) – 7.64%
AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. As of March 1, 2022, it operated approximately 950 theatres and 10,600 screens. The company was founded in 1920 and is headquartered in Leawood, Kansas.
NYSE ended the session with AMC rising 7.64% to $6.67 on Monday, after four successive sessions in a row of losses. NYSE jumped 0.14% to $15,486.46, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
: AMC stock soars more than 13% a day before quarterly resultsShares of AMC Entertainment Inc. surged 13.6% toward a 12-week high in afternoon trading Monday, a day before the movie theater operator is scheduled to report fourth-quarter results.
Earnings Per Share
As for profitability, AMC has a trailing twelve months EPS of $-39.15.
Moving Average
AMC’s worth is way above its 50-day moving average of $5.17 and way below its 200-day moving average of $9.58.
Yearly Top and Bottom Value
AMC’s stock is valued at $6.67 at 16:32 EST, way under its 52-week high of $34.33 and way higher than its 52-week low of $3.77.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.9%, now sitting on 4.09B for the twelve trailing months.
More news about AMC.
7. iShares FTSE EPRA/NAREIT Europe (IFEU) – 7.21%
NASDAQ ended the session with iShares FTSE EPRA/NAREIT Europe jumping 7.21% to $35.08 on Monday while NASDAQ jumped 0.63% to $11,466.98.
Earnings Per Share
As for profitability, iShares FTSE EPRA/NAREIT Europe has a trailing twelve months EPS of $3.47.
More news about iShares FTSE EPRA/NAREIT Europe.
8. Chart Industries (GTLS) – 6.07%
Chart Industries, Inc. manufactures and sells engineered equipment for the energy and industrial gas industries worldwide. The company operates through four segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products, and Repair, Service & Leasing. It provides bulk and packaged gas cryogenic solutions for the storage, distribution, vaporization, and application of industrial gases; cryogenic trailers, ISO containers, bulk storage tanks, loading facilities, and regasification equipment for delivering liquefied natural gas (LNG) into virtual pipeline applications; and large vacuum insulated storage tanks as equipment for purchasers of standard liquefaction plants. The company also offers process technology, liquefaction train, and critical equipment for the LNG, including small to mid-scale facilities, floating LNG applications, and large base-load export facilities; brazed aluminum, Core-in-Kettle, heat exchangers, cold boxes, air cooled heat exchangers, pressure vessels, and pipe works; and air cooled heat exchangers and axial cooling fans for the power, heating, ventilation, air conditioning, and refining applications. In addition, it provides highly engineered equipment that is used in specialty end-market applications for hydrogen, LNG, biogas, CO2 Capture, food and beverage, aerospace, lasers, cannabis, and water treatment; and cryogenic components, including vacuum insulated pipes, specialty liquid nitrogen, end-use equipment, and cryogenic flow meters. Additionally, it provides extended warranties, plant start-up, parts, 24/7 support, monitoring and process optimization, repairing, maintenance, and upgrading services; plant services on equipment, including brazed aluminum heat exchangers, cold boxes, etc.; and service locations that undertake installation, service, repair, maintenance, and refurbishment of cryogenic products, as well as equipment leasing solutions. The company was founded in 1859 and is based in Ball Ground, Georgia.
NASDAQ ended the session with Chart Industries rising 6.07% to $138.87 on Monday while NASDAQ jumped 0.63% to $11,466.98.
Earnings Per Share
As for profitability, Chart Industries has a trailing twelve months EPS of $8.65.
PE Ratio
Chart Industries has a trailing twelve months price to earnings ratio of 16.06. Meaning, the purchaser of the share is investing $16.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.82%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.5%, now sitting on 1.55B for the twelve trailing months.
More news about Chart Industries.
9. Marathon (MARA) – 5.92%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines cryptocurrencies with a focus on the blockchain ecosystem and the generation of digital assets in United States. As of December 31, 2021, it had approximately 8,115 bitcoins, which included the 4,794 bitcoins held in the investment fund. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Marathon rising 5.92% to $7.07 on Monday, following the last session’s downward trend. NASDAQ jumped 0.63% to $11,466.98, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-0.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -41.77%.
Moving Average
Marathon’s worth is way higher than its 50-day moving average of $6.07 and way under its 200-day moving average of $9.25.
More news about Marathon.
10. Baidu (BIDU) – 5.61%
Baidu, Inc. offers internet search services in China. It operates through Baidu Core and iQIYI segments. The company offers Baidu App to access search, feed, and other services using mobile devices; Baidu Search to access its search and other services; Baidu Feed that provides users with personalized timeline based on their demographics and interests; and Haokan, a short video app. It also provides Baidu Knows, an online community where users can ask questions to other users; Baidu Wiki; Baidu Healthcare Wiki; Baidu Wenku; Baidu Scholar; Baidu Experience; Baidu Post; Baidu Maps, a voice-enabled mobile app that provides travel-related services; Baidu Drive; Baijiahao; and DuerOS, a smart assistant platform. In addition, it offers online marketing services, which include pay for performance, an auction-based services that allow customers to bid for priority placement of paid sponsored links and reach users who search for information related to their products or services; other marketing services that include display-based marketing services and other online marketing services based on performance criteria other than cost per click; mobile ecosystem, a portfolio of apps, including Baidu App, Haokan, and Baidu Post; various cloud services and solutions, such as platform as a service, software as a service, and infrastructure as a service; self-driving services, including maps, automated valet parking, autonomous navigation pilot, electric vehicles, and robotaxi fleets, as well as Xiaodu smart devices. Further, the company provides iQIYI, AN online entertainment service, including original and licensed content; other video content and membership; and online advertising services. Baidu, Inc. has strategic partnership with Zhejiang Geely Holding Group. The company was formerly known as Baidu.com, Inc. Baidu, Inc. was incorporated in 2000 and is headquartered in Beijing, China.
NASDAQ ended the session with Baidu rising 5.61% to $139.94 on Monday, following the last session’s downward trend. NASDAQ rose 0.63% to $11,466.98, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Baidu has a trailing twelve months EPS of $10.03.
PE Ratio
Baidu has a trailing twelve months price to earnings ratio of 13.95. Meaning, the purchaser of the share is investing $13.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.53%.
Sales Growth
Baidu’s sales growth is 3.6% for the current quarter and 10.6% for the next.
More news about Baidu.
Losers Today
1. Inogen (INGN) – -31.39%
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
NASDAQ ended the session with Inogen sliding 31.39% to $15.89 on Monday, after two consecutive sessions in a row of losses. NASDAQ rose 0.63% to $11,466.98, following the last session’s downward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Inogen has a trailing twelve months EPS of $-1.52.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.09%.
Sales Growth
Inogen’s sales growth is 17.1% for the current quarter and 3.3% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.3%, now sitting on 377.24M for the twelve trailing months.
More news about Inogen.
2. Infinity Pharmaceuticals (INFI) – -13.32%
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 1/1b clinical trials for the treatment of triple negative breast cancer, solid tumors, and ovarian cancer. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts.
NASDAQ ended the session with Infinity Pharmaceuticals sliding 13.32% to $0.24 on Monday, after two sequential sessions in a row of losses. NASDAQ jumped 0.63% to $11,466.98, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Infinity Pharmaceuticals has a trailing twelve months EPS of $-0.45.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -439.96%.
Moving Average
Infinity Pharmaceuticals’s worth is way below its 50-day moving average of $0.58 and way below its 200-day moving average of $0.85.
Revenue Growth
Year-on-year quarterly revenue growth grew by 66.4%, now sitting on 2.5M for the twelve trailing months.
Yearly Top and Bottom Value
Infinity Pharmaceuticals’s stock is valued at $0.24 at 16:32 EST, way under its 52-week high of $1.76 and higher than its 52-week low of $0.23.
Sales Growth
Infinity Pharmaceuticals’s sales growth is 26.4% for the current quarter and 7.4% for the next.
More news about Infinity Pharmaceuticals.
3. FuboTV (FUBO) – -12.72%
fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.
NYSE ended the session with FuboTV sliding 12.72% to $2.03 on Monday, after five consecutive sessions in a row of gains. NYSE rose 0.14% to $15,486.46, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.
: fubotv stock jumps after much narrower loss than expected and revenue beatShares of FuboTV Inc. jumped 3.9% in premarket trading Monday, after the live TV streaming platform reported a much narrower-than-expected loss and revenue that rose above forecasts, as the company surpassed $1 billion in revenue for the year for the first time.
Earnings Per Share
As for profitability, FuboTV has a trailing twelve months EPS of $-3.735.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -66.53%.
Yearly Top and Bottom Value
FuboTV’s stock is valued at $2.03 at 16:32 EST, way below its 52-week low of $2.32.
Revenue Growth
Year-on-year quarterly revenue growth grew by 102.2%, now sitting on 760.65M for the twelve trailing months.
More news about FuboTV.
4. Heron Therapeutics (HRTX) – -11.63%
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing HTX-011, an investigational, dual-acting, and fixed-dose combination of the local anesthetic bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug meloxicam, which is in Phase III clinical trials for pain management; and HTX-034, which is in Phase Ib/II clinical trials for postoperative pain management. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
NASDAQ ended the session with Heron Therapeutics falling 11.63% to $2.28 on Monday, after two sequential sessions in a row of losses. NASDAQ jumped 0.63% to $11,466.98, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Heron Therapeutics has a trailing twelve months EPS of $-2.504.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -306.88%.
Sales Growth
Heron Therapeutics ‘s sales growth is 30.2% for the ongoing quarter and 31.4% for the next.
Yearly Top and Bottom Value
Heron Therapeutics ‘s stock is valued at $2.28 at 16:32 EST, way under its 52-week high of $7.56 and above its 52-week low of $2.19.
Moving Average
Heron Therapeutics ‘s value is way below its 50-day moving average of $2.70 and way under its 200-day moving average of $3.33.
Volume
Today’s last reported volume for Heron Therapeutics is 2707560 which is 12.17% above its average volume of 2413700.
More news about Heron Therapeutics .
5. LendingTree (TREE) – -10.17%
LendingTree, Inc., through its subsidiary, LT Intermediate Company, LLC, operates online consumer platform in the United States. It operates through three segments: Home, Consumer, and Insurance. The Home segment offers purchase mortgage, refinance mortgage, reverse mortgage, and home equity loans; lines of credit; and real estate brokerage services. The Consumer segment provides credit cards; personal, small business, student, and auto loans; deposit accounts; and other credit products, such as credit repair and debt settlement services. The Insurance segment includes information, tools, and access to insurance quote products, including home and automobile, through which consumers are matched with insurance lead aggregators to obtain insurance offers. LendingTree, Inc. also operates Student Loan Hero, a personal finance website dedicated to helping student loan borrowers manage their student debt; QuoteWizard.com, a marketplace for insurance comparison; ValuePenguin, a personal finance website that offers consumers objective analysis on various financial topics from insurance to credit cards; and Stash, a consumer investing and banking platform that offers a suite of personal investment accounts, traditional and Roth IRAs, custodial investment accounts, and banking services, including checking accounts and debit cards with a Stock-Back rewards program. The company was formerly known as Tree.com, Inc. and changed its name to LendingTree, Inc. in January 2015. LendingTree, Inc. was incorporated in 1996 and is headquartered in Charlotte, North Carolina.
NASDAQ ended the session with LendingTree falling 10.17% to $33.46 on Monday, following the last session’s downward trend. NASDAQ jumped 0.63% to $11,466.98, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, LendingTree has a trailing twelve months EPS of $-3.35.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.5%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LendingTree’s stock is considered to be overbought (>=80).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 142.9% and a negative 65.2%, respectively.
More news about LendingTree.
6. Professional Diversity Network (IPDN) – -9.1%
Professional Diversity Network, Inc. operates online professional networking communities with career resources in the United States. It operates in two segments, Professional Diversity Network (PDN Network) and National Association of Professional Women (NAPW Network). The company offers recruitment services, such as single and multiple job postings, recruitment media, talent recruitment communities, corporate memberships, hiring campaign marketing and advertising, e-newsletter marketing, and research and outreach services to various cultural groups and employers. It also provides consumer advertising and consumer marketing solutions through advertising and job postings on its Websites. In addition, the company operates a women-only professional networking organization. Professional Diversity Network, Inc. was incorporated in 2003 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Professional Diversity Network falling 9.1% to $6.94 on Monday while NASDAQ rose 0.63% to $11,466.98.
Earnings Per Share
As for profitability, Professional Diversity Network has a trailing twelve months EPS of $-0.46.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -98.56%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 7.83M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Professional Diversity Network’s EBITDA is -14.02.
Volume
Today’s last reported volume for Professional Diversity Network is 166557 which is 74.62% above its average volume of 95380.
More news about Professional Diversity Network.
7. Aspen Group (ASPU) – -9.07%
Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.
NASDAQ ended the session with Aspen Group dropping 9.07% to $0.16 on Monday while NASDAQ rose 0.63% to $11,466.98.
Earnings Per Share
As for profitability, Aspen Group has a trailing twelve months EPS of $-0.383.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.28%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 9.9%, now sitting on 74.29M for the twelve trailing months.
Volume
Today’s last reported volume for Aspen Group is 148177 which is 53.93% below its average volume of 321670.
More news about Aspen Group.
8. VerifyMe (VRME) – -6.84%
VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners the ability to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, authentication, serialization, and track and trace features for labels, packaging, and products. This segment also offers consumer engagement capabilities, custom printing of tamper evident labels, utilizing visible and invisible variable codes, and images printed with its proprietary inks. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Rochester, New York.
NASDAQ ended the session with VerifyMe falling 6.84% to $1.77 on Monday, after two successive sessions in a row of gains. NASDAQ rose 0.63% to $11,466.98, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, VerifyMe has a trailing twelve months EPS of $-1.483.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.7%.
Sales Growth
VerifyMe’s sales growth is 2547.1% for the present quarter and 3626.7% for the next.
More news about VerifyMe.
9. Xenetic Biosciences (XBIO) – -5.75%
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
NASDAQ ended the session with Xenetic Biosciences dropping 5.75% to $0.53 on Monday while NASDAQ jumped 0.63% to $11,466.98.
Earnings Per Share
As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-1.704.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.85%.
Volume
Today’s last reported volume for Xenetic Biosciences is 7250 which is 90.13% below its average volume of 73477.
More news about Xenetic Biosciences.
10. Infinera Corporation (INFN) – -5.27%
Infinera Corporation provides optical transport networking equipment, software, and services worldwide. The company's product portfolio includes Infinera Groove series for modular and sled-based platforms to support a various transport network applications; Infinera 7300 series, an SDN-ready coherent optical transport system; Infinera FlexILS open optical line system that connects various Infinera and third-party terminal equipment platforms over long-distance fiber optic cable providing switching, multiplexing, amplification, and management channels; and Infinera 7090 and 7100 series for transport platforms. It also offers Infinera XTM series, a packet-optical transport platform that enables metro connectivity solutions; Infinera XTC series, a multi-terabit packet optical transport platforms that integrates digital OTN switching and optical WDM transmission; Infinera mTera series, a network transport solution; and Infinera XT series, a platform that is designed to power cloud scale network services over metro, DCI, long-haul, and subsea networks. The company provides Infinera Cloud Xpress Family that is designed to meet the needs of internet content providers (ICPs), communication service providers, internet exchange service providers, enterprises, and other large-scale data center operators; Infinera DRX series for routers; and Infinera 8600 series for SDN-ready Internet Protocol/MPLS routers. It also offers Infinera CNOS, a hardware-independent network operating system; Transcend software suite; and system software and customer support services. The company also serves telecommunications service providers, ICPs, cable providers, wholesale carriers, research and education institutions, large enterprises, and government entities. It markets and sells its products and related support services primarily through its direct sales force. The company was formerly known as Zepton Networks. The company was incorporated in 2000 and is headquartered in San Jose, California.
NASDAQ ended the session with Infinera Corporation falling 5.27% to $6.83 on Monday while NASDAQ jumped 0.63% to $11,466.98.
Earnings Per Share
As for profitability, Infinera Corporation has a trailing twelve months EPS of $-0.62.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -30.21%.
Yearly Top and Bottom Value
Infinera Corporation’s stock is valued at $6.83 at 16:32 EST, way under its 52-week high of $9.25 and way higher than its 52-week low of $4.26.
Sales Growth
Infinera Corporation’s sales growth is 13.3% for the ongoing quarter and 13.5% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Infinera Corporation’s EBITDA is 1.34.
Volume
Today’s last reported volume for Infinera Corporation is 3788900 which is 85.78% above its average volume of 2039460.
More news about Infinera Corporation.
Stay up to date with our winners and losers daily report
